Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Bauman, Tyler M ^a   Nicholson, Tristan M ^a   Abler, Lisa L ^b   Eliceiri, Kevin W ^c   Huang, Wei ^a   Vezina, Chad M ^b   Ricke, William A ^a,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRILLAR COLLAGEN; FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR; COLLAGEN;

AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLLAGEN THICKNESS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MALE; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; THICKNESS; CASE CONTROL STUDY; METABOLISM; PATHOLOGY; PROSTATE;

CASE-CONTROL STUDIES; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; MALE; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 84907495368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109102     Document Type: Article

References (39)

1. Irwin DE, Kopp ZS, Agatep B, Milsom I., Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU International 108: 1132-1138.
2. Parsons JK, Bergstrom J, Silberstein J., Barrett-Connor E (2008) Prevalence and characteristics of lower urinary tract symptoms in men aged. or =80 years. Urology 72: 318-321.
3. Abrams P, Cardozo L, Fall M., Griffiths D, Rosier P, et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics 21: 167-178.
4. Nickel JC (2006) BPH: costs and treatment outcomes. American Journal of Managed Care 12: S141-148.
5. Chapple CR, Roehrborn CG (2006) A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. European Urology 49: 651-658.
6. Ma J, Gharaee-Kermani M, Kunju L., Hollingsworth JM, Adler J, et al. (2012) Prostatic Fibrosis is Associated with Lower Urinary Tract Symptoms. The Journal of Urology 188: 1375-1381.
7. Rodriguez-Nieves JA, Macoska JA (2013) Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol 10: 546-550.
8. Cantiello F, Cicione A, Salonia A., Autorino R, Tucci L, et al. (2013) Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology 81: 1018-1023.
9. Nicholson TM, Sehgal PD, Drew S.A., Huang W., Ricke WA (2013) Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation 85: 140-149.
10. Huang W, Hennrick K, Drew S (2013) A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Human Pathology 44: 29-38.
11. Bauman TM, Sehgal PD, Johnson K.A., Pier T., Bruskewitz RC, et al. (2014) Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues. Prostate 74: 923-932.
12. Masson PJ (1929) Some histological methods: trichrome stainings and their preliminary technique. J Tech Methods 12: 75.
13. Rich L, Whittaker P (2005) Collagen and Picrosirius Red staining: a polarized light assessment of fibrillar hue and spatial distribution. Brazilian Journal of Morphological Sciences 22: 97-104.
14. Puchtler H, Waldrop FS, Valentine LS (1973) Polarization Microscopic Studies of Connective Tissue Stained with Picro-Sirius Red FBA. Beitrage zur Pathologie 150: 174-187.
15. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
16. Barcus CE, Keely PJ, Eliceiri K.W., Schuler LA (2013) Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. J Biol Chem 288: 12722-12732.
17. Drifka CR, Eliceiri KW, Weber S.M., Kao WJ (2013) A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma. Lab Chip 13: 3965-3975.
18. Hanson KP, Jung JP, Tran Q.A., Hsu SP, Iida R, et al. (2013) Spatial and temporal analysis of extracellular matrix proteins in the developing murine heart: a blueprint for regeneration. Tissue Eng Part A 19: 1132-1143.
19. Reusch LM, Feltovich H, Carlson L.C., Hall G., Campagnola PJ, et al. (2013) Nonlinear optical microscopy and ultrasound imaging of human cervical structure. J Biomed Opt 18: 031110.
20. Zhang K, Corsa CA, Ponik S.M., Prior JL, Piwnica-Worms D, et al. (2013) The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol 15: 677-687.
21. Cox G, Kable E, Jones A., Fraser I, Manconi F, et al. (2003) 3-dimensional imaging of collagen using second harmonic generation. Journal of Structural Biology 141: 53-62.
22. Tsai MR, Chiu YW, Lo M.T., Sun CK (2010) Second-harmonic generation imaging of collagen fibers in myocardium for atrial fibrillation diagnosis. J Biomed Opt 15: 026002.
23. Schindelin J, Arganda-Carreras I, Frise E., Kaynig V, Longair M, et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.
24. Hollingsworth JM, Wei JT (2006) Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia. Rev Urol 8 Suppl 3: S9-S15.
25. Roehrborn CG, Boyle P, Nickel J.C., Hoefner K., Andriole G (2002) Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60: 434-441.
26. McConnell JD, Roehrborn CG, Bautista O.M., Andriole GL Jr, Dixon CM, et al. (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine 349: 2387-2398.
27. Smith RD, Patel A (2011) Transurethral resection of the prostate revisited and updated. Curr Opin Urol 21: 36-41.
28. Grimm PC, Nickerson P, Gough J., McKenna R, Stern E, et al. (2003) Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. Journal of the American Society of Nephrology 14: 1662-1668.
29. Diaz Encarnacion MM, Griffin MD, Slezak J.M., Bergstralh EJ, Stegall MD, et al. (2004) Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant 4: 248-256.
30. Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. Journal of Experimental Medicine 208: 1339-1350.
31. Grewal P, Martin P (2009) Care of the cirrhotic patient. Clin Liver Dis 13: 331-340.
32. Lee NG, Xue H, Lerner LB (2012) Trends and attitudes in surgical management of benign prostatic hyperplasia. Can J Urol 19: 6170-6175.
33. Rifkin MD, McGlynn ET, Choi H (1989) Echogenicity of prostate cancer correlated with histologic grade and stromal fibrosis: endorectal US studies. Radiology 170: 549-552.
34. Sfanos KS, De Marzo AM (2012) Prostate cancer and inflammation: the evidence. Histopathology 60: 199-215.
35. Buehler MJ (2006) Nature designs tough collagen: explaining the nanostructure of collagen fibrils. Proceedings of the National Academy of Sciences of the United States of America 103: 12285-12290.
36. Vogel WF (2001) Collagen-receptor signaling in health and disease. European Journal of Dermatology 11: 506-514.
37. Kruithof-Dekker IG, Tetu B, Janssen P.J., Van der Kwast TH (1996) Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy. Journal of Urology 156: 1194-1197.
38. Aida-Yasuoka K, Peoples C, Yasuoka H., Hershberger P, Thiel K, et al. (2013) Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther 15: R10.
39. Juodziukyniene N, Aniuliene A, Pangonyte D (2010) Effect of age, hyperplasia and atrophy on collagen parameters in dog prostates. Pol J Vet Sci 13: 479-485.